Worldwide Industry for Drug-Eluting Stents to 2024 - Impact of the COVID-19 Pandemic
Dublin, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The "Global Drug-Eluting Stents Market" report has been added to ResearchAndMarkets.com's offering.
This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of products, applications and end-user.
By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end-user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.
By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
The Report Includes:
20 data tables and 18 additional tables
An overview of the global market for drug-eluting stents within the medical devices industry
Estimation of the market size and analyses of market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
Market share analysis of the drug-eluting stents based on product, application, end-use, and region
Identification of segments with high growth potential and analysis of future applications of each of the segments
Assessment of market dynamics for drug-eluting stents with market drivers and restraints explained, medical device regulations, market background and pipeline analysis of the stents
Coverage of prevalence and epidemiology of cardiovascular disease and description of coronary artery disease (CAD) and peripheral artery disease (PAD)
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Company profiles of the leading market players, including Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., Medtronic Plc and Cook Medical Inc.
The global market growth is attributed to the growing prevalence of cardiovascular diseases, a rise in the world's geriatric population, and growing demand for minimally invasive procedures.
There has been remarkable growth in the development of coronary stents to avoid restenosis and thrombosis. Improvements include progress in the design and conformation of metallic or resorbable structures, with an adequate balance between trackability and radial force. Also noted is the development of antiproliferative drugs and polymers to control release and allow adequate endothelialization and optimal duration of the antiplatelet regimen. These developments led to growth in the drug-eluting stent market over the forecast period.
Drug-eluting stents are coated with a drug and polymer, designed to allow for a controlled and consistent release of the drug from the stent surface into the artery walls. Both the amount of drug and release rate has been determined so that healing can occur while allowing the processes leading to restenosis to be minimized, reducing the need for additional treatment in the stented area.
Rising incidence of CVD, heart failure, and coronary heart disease cases come with a growing prevalence of obesity, diabetes, and high blood pressure, globally. These phenomena are anticipated to fuel drug-eluting stents market growth over the forecast period.
Key Topics Covered:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Research Reports
Chapter 2 Summary and Highlights
Market Highlights: Drug-Eluting Stents
Chapter 3 Medical Device Regulations
Medical Device Definition and Classification
Regulations in the U.S.
Code of Federal Regulations
Regulations in Europe
Regulations in Japan
Chapter 4 Drug-Eluting Stents: Pipeline Analysis
Overview
Chapter 5 Drug-Eluting Stents: Market Background
Introduction
Market Evolution
Coating and Polymers
Drugs Used in DESs
Cardiovascular Diseases (CVDs)
Common Types of CVD
Symptoms of CVD
Risk Factors: CVD
Treatment for CVD
Chapter 6 Drug-Eluting Stents: Market Dynamics
Market Dynamics
Market Drivers
Market Restraints
Chapter 7 Impact of COVID-19 Pandemic
Introduction
Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Global Confirmed COVID-19 Cases and Deaths
Collaboration Between Organizations and Governments
Spread of Disease
Current Status and Impact on MedTech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
Chapter 8 Market Breakdown, by Product
Global Market for Drug-Eluting Stents, by Product
Polymer-Based Drug-Eluting Stents
Market Size and Forecast
Market Analysis
Polymer-Free Drug-Eluting Stents
Market Size and Forecast
Market Analysis
Chapter 9 Market Breakdown, by Application
Global Market for Drug-Eluting Stents, by Application
Coronary Artery Disease (CAD)
Market Size and Forecast
Market Analysis
Peripheral Artery Disease (PAD)
Market Size and Forecast
Market Analysis
Chapter 10 Market Breakdown, by End User
Global Market for Drug-Eluting Stents, by End User
Hospitals
Market Size and Forecast
Market Analysis
Ambulatory Surgical Centers
Market Size and Forecast
Market Analysis
Specialty Centers and Clinics
Market Size and Forecast
Market Analysis
Chapter 11 Market Breakdown, by Region
Global Market for Drug-Eluting Stents, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Latin America
Middle East and Africa
Chapter 12 Competitive Landscape
Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches and Partnerships
Chapter 13 Company Profiles
Abbott
Alvimedica
B. Braun Melsungen Ag
Biosensors International
Biotronik Se & Co. Kg
Boston Scientific Corp.
Cook Medical Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
Medtronic Plc
Terumo Corp.
Chapter 14 Appendix: List of Acronyms
For more information about this report visit https://www.researchandmarkets.com/r/7ps9k3
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900